Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer.
Luszczak S, Kumar C, Sathyadevan VK, Simpson BS, Gately KA, Whitaker HC, Heavey S. Luszczak S, et al. Among authors: simpson bs. Signal Transduct Target Ther. 2020 Jan 31;5(1):7. doi: 10.1038/s41392-020-0109-y. Signal Transduct Target Ther. 2020. PMID: 32296034 Free PMC article. Review.
Prostate cancer visibility on multiparametric magnetic resonance imaging: high Gleason grade and increased tumour volume are not the only important histopathological features.
Norris JM, Carmona Echeverria LM, Simpson BS, Allen C, Ball R, Freeman A, Kelly D, Kirkham A, Kasivisvanathan V, Whitaker HC, Emberton M. Norris JM, et al. Among authors: simpson bs. BJU Int. 2020 Aug;126(2):237-239. doi: 10.1111/bju.15085. Epub 2020 May 18. BJU Int. 2020. PMID: 32319152 No abstract available.
Re: Gregory T. Chesnut, Emily A. Vertosick, Nicole Benfante, et al. Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance. Eur Urol 2020;77:501-7.
Simpson BS, Carmona Echeverria LM, Norris JM, Ahmed HU, Moore CM, Whitaker HC. Simpson BS, et al. Eur Urol. 2020 Sep;78(3):e106-e107. doi: 10.1016/j.eururo.2020.05.002. Epub 2020 Jun 8. Eur Urol. 2020. PMID: 32527691 No abstract available.
Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer.
Luszczak S, Simpson BS, Stopka-Farooqui U, Sathyadevan VK, Echeverria LMC, Kumar C, Costa H, Haider A, Freeman A, Jameson C, Ratynska M, Ben-Salha I, Sridhar A, Shaw G, Kelly JD, Pye H, Gately KA, Whitaker HC, Heavey S. Luszczak S, et al. Among authors: simpson bs. Sci Rep. 2020 Sep 1;10(1):14380. doi: 10.1038/s41598-020-71263-9. Sci Rep. 2020. PMID: 32873828 Free PMC article.
95 results